The news bargaining incentive touched all the right buttons at the White House. And not in a Monica Lewinsky way, fortunately ...

The first participant has been dosed in an investigator-led Phase 2 trial testing pegsebrenatide as a potential treatment for ...

Orthocell has reported first commercial sales of Remplir in Canada, marking a key milestone in the regenerative medicine ...

Orthocell Ltd (ASX:OCC, OTC:ORHHF) has achieved first commercial sales of its flagship nerve repair device Remplir™ in Canada ...

Just like vertebrates, cephalopods — such as octopuses and squid — have elaborate brains. Neuroscientists are flocking to ...

Affective tactile memory explains how touch lingers in our minds, influencing how we feel, connect, and respond to ...

Hinge Health boosted its full-year revenue outlook by $64 million as the company reported a stronger-than-expected first ...

A newly identified trigger of brain inflammation could offer a fresh target for slowing Alzheimer’s progression.

An inherited form of blindness directly comparable to a common inherited optic nerve disease in humans has been discovered in ...

From robot-run households to self-writing code, futurists at Dreame’s event sketch an AI future that’s exciting—and a little ...